Dr. Jeffrey Neul is the Director of the Vanderbilt Kennedy Center and the Annette Shaffer Eskind Professor of Pediatrics at Vanderbilt University Medical Center. His clinical practice and research focus is on Rett syndrome and related disorders. His laboratory-based research explores disease mechanisms, tests new therapeutics, and discovers and evaluates biomarkers of disease improvement. His clinical research focuses on longitudinal natural history studies and the development of outcome measures and biomarkers. He has been involved in multiple industry sponsored clinical trials in Rett syndrome and is leading an investigator initiated study exploring the safety of oral ketamine in Rett syndrome.